Related Experiment Video

Updated: May 18, 2026

Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm
04:56

Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm

Published on: August 1, 2025

Treatment of coronary aneurysms with covered stents: a review with illustrated case

Mehmood Zeb1, Daniel B McKenzie, Paul A Scott

  • 1Wessex Cardiothoracic Centre, Southampton General Hospital, Hampshire, United Kingdom. mehmoodzeb@hotmail.com

The Journal of Invasive Cardiology
|September 8, 2012
PubMed

Insights

Coronary artery aneurysms (CAAs) affect 5% of patients. Treatment remains challenging due to unknown outcomes of interventions like covered stents.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Coronary artery aneurysms (CAAs) are identified in approximately 5% of individuals undergoing coronary angiography.
  • While often linked to coronary stenosis, the optimal management strategy for CAAs lacks a definitive consensus.
  • Large CAAs can induce turbulent blood flow, increasing risks of thrombus formation and obstruction, even without significant stenosis.

Observation:

  • The pathophysiology, clinical significance, and therapeutic approaches for CAAs require further elucidation.
  • Percutaneous implantation of covered stents presents a less invasive alternative to surgery for CAA treatment.
  • The long-term efficacy and safety data for covered stent interventions in CAAs are currently limited.

Findings:

  • This review synthesizes current literature on coronary artery aneurysms.
  • It discusses the underlying mechanisms, clinical relevance, and available treatment modalities.
  • A case study with detailed imaging (coronary angiography, intravascular ultrasound, transesophageal echocardiography) illustrates management challenges.

Implications:

  • Understanding CAA pathophysiology is crucial for effective clinical management.
  • Further research is needed to establish best practices for treating CAAs, particularly regarding stent-based interventions.
  • Improved treatment strategies for CAAs can mitigate risks of thrombus formation and coronary obstruction.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...